Form F-6 POS - Post-effective amendments for immediately effective filing:
SEC Accession No. 0001193805-25-000286
Filing Date
2025-03-12
Accepted
2025-03-12 07:46:42
Documents
2

Document Format Files

Seq Description Document Type Size
1 e664262_f6pos-amarin.htm F-6 POS 51933
2 e664262_ex99-ai.htm EX-99.(AI) 206702
  Complete submission text file 0001193805-25-000286.txt   260492
Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60 353 1 6699 020
AMARIN CORP PLC\UK (Subject) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: F-6 POS | Act: 33 | File No.: 333-228591 | Film No.: 25730012
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 388 GREENWICH STREET, 14TH FLOOR NEW YORK NY 10013
Business Address 388 GREENWICH STREET, 14TH FLOOR NEW YORK NY 10013 212-816-6647
Citibank,N.A./ADR (Filed by) CIK: 0001472033 (see all company filings)

EIN.: 521568099 | State of Incorp.: DC | Fiscal Year End: 1231
Type: F-6 POS
(CF Office: International Corp Fin)